🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.810
+0.130 (7.74%)
At close: Nov 20, 2026, 4:00 PM EST
1.870
+0.060 (3.31%)
After-hours: Nov 20, 2026, 7:59 PM EST

Pyxis Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-86.71-79.62-77.33-73.79-120.72-75.98
Depreciation & Amortization
3.964.512.981.930.710.65
Asset Writedown & Restructuring Costs
--20.96-9.2820
Loss (Gain) From Sale of Investments
-1.15-2.96-6.11-4.79--
Loss (Gain) on Equity Investments
-----0.05
Stock-Based Compensation
10.1511.812.9516.9515.766.44
Other Operating Activities
0.930.820.70.661.136.84
Change in Accounts Payable
-1.636.031.2-3.51-8.334.64
Change in Unearned Revenue
---7.661--
Change in Other Net Operating Assets
3.52-4.08-3.2-9.1612.832.03
Operating Cash Flow
-70.93-63.5-57.67-70.71-89.34-35.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.01-0.24-6.73-6.4-0.54
Cash Acquisitions
---6.66--
Investment in Securities
16.6458.878.39-104.78--0.05
Investing Cash Flow
16.6458.868.16-104.85-6.4-0.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
49.410.7451.876.370.18152.46
Repurchase of Common Stock
-0.18-0.15-0.24-0.45--
Other Financing Activities
--7.7---
Financing Cash Flow
49.220.5959.335.930.18304.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.06-4.059.81-169.63-95.55268.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-70.93-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Growth
------
Free Cash Flow Margin
-642.57%-458.30%-358.66%---
Free Cash Flow Per Share
-1.04-1.02-0.99-1.94-2.90-4.22
Levered Free Cash Flow
-36.99-31.38-33.79-43.21-57.39-25.47
Unlevered Free Cash Flow
-36.99-31.38-33.79-43.21-57.39-25.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.090.090.010--
Cash Income Tax Paid
1.381.380.160.050.02-
Change in Working Capital
1.891.94-11.82-11.664.56.68
SEC Filings: 10-K · 10-Q